Abstract
Recent American College of Cardiology/American Heart Association guidelines recommend mitral valve repair in asymptomatic patients at an experienced center, assuming the likelihood for repair is ≥ 90%. This has raised the question of how you define an experienced center (or surgeon). This article describes thoughts on the criteria that should make up a Center of Excellence: surgical training; intraoperative echocardiography; high volume; cardiology involvement; audit of clinical outcomes and outcomes of repair; and associated surgery for atrial fibrillation and tricuspid regurgitation. High-volume programs (≥ 140 mitral valve operations per year) have the lowest mortality and highest repair rate. Although some pathologic conditions may be repaired with a high degree of certainty by experienced (nonreferent) surgeons, considerable variation still exists. Recent publications of repair rates and outcomes using minimally invasive surgery and conventional surgery highlight this variability.
Similar content being viewed by others
References and Recommended Reading
Braunberger E, Deloche A, Berrebi A, et al.: Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation 2001, 104(12 Suppl 1):I8–I11.
Mohty D, Orszulak TA, Schaff HV, et al.: Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 2001, 104(12 Suppl 1):I1–I7.
Suri RM, Schaff HV, Dearani JA, et al.: Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 2006, 82:819–826.
Fedak PW, McCarthy PM, Bonow RO: Evolving concepts and technologies in mitral valve repair. Circulation 2008, 117:963–974.
McCarthy PM, McGee EC, Rigolin VH, et al.: Initial clinical experience with Myxo-ETlogix mitral valve repair ring. J Thorac Cardiovasc Surg 2008, 136:73–81.
Filsoufi F, Aklog L, Byrne JG, et al.: Current results of combined coronary artery bypass grafting and mitral annuloplasty in patients with moderate ischemic mitral regurgitation. J Heart Valve Dis 2004, 13:747–753.
Acker MA, Bolling S, Shemin R, et al.: Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006, 132:568–577; 577.e1–577.e4.
Shuhaiber J, Anderson RJ: Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg 2007, 31:267–275.
Gillinov AM, Blackstone EH, Nowicki ER, et al.: Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg 2008, 135:885–893; 893.e1–893.e2.
Adams DH, Anyanwu A: Pitfalls and limitations in measuring and interpreting the outcomes of mitral valve repair. J Thorac Cardiovasc Surg 2006, 131:523–529.
Brown ML, Abel MD, Click RL, et al.: Systolic anterior motion after mitral valve repair: is surgical intervention necessary? J Thorac Cardiovasc Surg 2007, 133:136–143.
McGee EC, Gillinov AM, Blackstone EH, et al.: Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004, 128:916–924.
Flameng W, Herijgers P, Bogaerts K: Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 2003, 107:1609–1613.
Savage EB, Ferguson TB Jr, DiSesa VJ: Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 2003, 75:820–825.
McCarthy PM, Malaisrie SC: Mitral valve repair and replacement, including associated atrial fibrillation and tricuspid regurgitation. In Valvular Heart Disease: A Companion to Braunwald’s Heart Disease, edn 3. Edited by Otto CM, Bonow RO. Philadelphia, PA: Saunders/Elsevier; 2009 (in press).
Bonow RO, Carabello BA, Kanu C, et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84–e231.
Madaric J, Watripont P, Bartunek J, et al.: Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J 2007, 154:180–185.
Russo A, Grigioni F, Avierinos JF, et al.: Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol 2008, 51:1203–1211.
Bridgewater B, Hooper T, Munsch C, et al.: Mitral repair best practice: proposed standards. Heart 2006, 92:939–944.
Gammie JS, O’Brien SM, Griffith BP, et al.: Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 2007, 115:881–887.
Ngaage DL, Schaff HV, Mullany CJ, et al.: Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 2007, 84:434–442; discussion 442–433.
Ngaage DL, Schaff HV, Barnes SA, et al.: Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery? Ann Thorac Surg 2006, 82:1392–1399.
Ngaage DL, Schaff HV, Mullany CJ, et al.: Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting? J Thorac Cardiovasc Surg 2007, 133:182–189.
Quader MA, McCarthy PM, Gillinov AM, et al.: Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg 2004, 77:1514–1522; discussion 1522–1524.
Abreu Filho CA, Lisboa LA, Dallan LA, et al.: Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation 2005, 112(9 Suppl):I20–I25.
Akpinar B, Sanisoglu I, Guden M, et al.: Combined off-pump coronary artery bypass grafting surgery and ablative therapy for atrial fibrillation: early and mid-term results. Ann Thorac Surg 2006, 81:1332–1337.
Deneke T, Khargi K, Grewe PH, et al.: Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur Heart J 2002, 23:558–566.
Doukas G, Samani NJ, Alexiou C, et al.: Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA 2005, 294:2323–2329.
Schuetz A, Schulze CJ, Sarvanakis KK, et al.: Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. Eur J Cardiothorac Surg 2003, 24:475–480; discussion 480.
Gammie JS, Haddad M, Milford-Beland S, et al.: Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 2008, 85:909–914.
McCarthy PM: Adjunctive procedures in degenerative mitral valve repair: tricuspid valve and atrial fibrillation surgery. Semin Thorac Cardiovasc Surg 2007, 19:121–126.
Calkins H, Brugada J, Packer DL, et al.: HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007, 4:816–861.
McCarthy PM: Valve surgery for patients with left ventricular dysfunction. In Heart Failure: A Combined Medical and Surgical Approach. Edited by McCarthy PM, Young JB. Malden, MA: Blackwell Futura; 2007:153–173.
McCarthy PM, Bhudia SK, Rajeswaran J, et al.: Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004, 127:674–685.
Matsunaga A, Duran CM: Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation 2005, 112(9 Suppl):I453–I457.
Tang GH, David TE, Singh SK, et al.: Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 2006, 114(1 Suppl):I577–I581.
Wu AH, Aaronson KD, Bolling SF, et al.: Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005, 45:381–387.
Nath J, Foster E, Heidenreich PA: Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004, 43:405–409.
Bernal JM, Morales D, Revuelta C, et al.: Reoperations after tricuspid valve repair. J Thorac Cardiovasc Surg 2005, 130:498–503.
Dreyfus GD, Corbi PJ, Chan KM, Bahrami T: Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005, 79:127–132.
Filsoufi F, Salzberg SP, Coutu M, Adams DH: A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. Ann Thorac Surg 2006, 81:2273–2277.
Adams DH, Anyanwu AC: The cardiologist’s role in increasing the rate of mitral valve repair in degenerative disease. Curr Opin Cardiol 2008, 23:105–110.
Chitwood WR Jr, Rodriguez E, Chu MW, et al.: Robotic mitral valve repairs in 300 patients: a single-center experience. J Thorac Cardiovasc Surg 2008, 136:436–441.
Umakanthan R, Leacche M, Petracek MR, et al.: Safety of minimally invasive mitral valve surgery without aortic cross-clamp. Ann Thorac Surg 2008, 85:1544–1549; discussion 1549–1550.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCarthy, P.M. When is your surgeon good enough? When do you need a “referent surgeon”?. Curr Cardiol Rep 11, 107–113 (2009). https://doi.org/10.1007/s11886-009-0017-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-009-0017-9